Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
86.19B | 77.33B | 71.58B | 69.20B | 75.76B | 68.92B | Gross Profit |
20.80B | 17.85B | 16.82B | 16.32B | 16.83B | 15.11B | EBIT |
2.23B | 2.23B | 1.64B | 1.68B | 2.31B | 834.00M | EBITDA |
3.32B | 3.44B | 3.08B | 3.00B | 3.31B | 1.89B | Net Income Common Stockholders |
1.40B | 1.45B | 1.19B | 1.33B | 1.40B | 360.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.88B | 3.96B | 2.36B | 1.24B | 2.87B | 1.78B | Total Assets |
40.49B | 38.09B | 33.50B | 32.17B | 32.62B | 31.04B | Total Debt |
5.47B | 6.79B | 5.33B | 5.32B | 6.22B | 6.74B | Net Debt |
582.00M | 2.83B | 2.97B | 4.07B | 3.35B | 4.96B | Total Liabilities |
20.09B | 18.72B | 15.72B | 15.45B | 17.15B | 17.02B | Stockholders Equity |
20.40B | 19.37B | 17.78B | 16.72B | 15.47B | 14.02B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.73B | 1.68B | 99.34M | 2.19B | 1.74B | Operating Cash Flow |
0.00 | 3.78B | 2.54B | 1.73B | 3.37B | 2.48B | Investing Cash Flow |
0.00 | -2.89B | -864.63M | -1.95B | -1.18B | -777.29M | Financing Cash Flow |
0.00 | 700.91M | -556.83M | -1.41B | -1.09B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.38B | 6.99 | 2.39% | 15.66% | 2.87% | ||
77 Outperform | ¥9.18B | 9.33 | 4.28% | 2.42% | 154.96% | ||
76 Outperform | ¥11.53B | 10.99 | 1.55% | 6.01% | -21.51% | ||
70 Outperform | ¥10.97B | 6.94 | 1.47% | 0.19% | 32.51% | ||
65 Neutral | $8.88B | 14.98 | 4.76% | 203.76% | 3.54% | -2.49% | |
55 Neutral | ¥12.26B | ― | 2.40% | 0.65% | -679.30% | ||
41 Neutral | ¥10.28B | ― | ― | -5.60% | -23.60% |